23 aug: Investorerne spejder efter svar fra centralbankchef ved Jackson H..
23 aug: Ambu fortsætter i vækstsporet og opjusterer
23-08-2018 07:59:01

Ambu A/S: Interim report Q3 2017/18

Relateret indhold
15 jan - 
Tirsdagens aktier: Stærk trio tippede C25 til spinkelt ..
15 jan - 
Aktier/middag: Lundbeck trækker C25-comeback i afventen..
11 jan - 
Fredagens aktier: Ambu endte i toppen i svagt negativt ..
Relateret debat
17 jan - 
Teknisk er der støtte ved ca 133, så jeg vil tro at en ..
16 jan - 
Mon ikke ned til et fornuftig P/E, det er nok det Mafia..
16 jan - 
Short angreb....AN storsælger

Ambu reports organic growth of 17% in Q3 and raises its outlook for this year's EBIT margin by 1 percentage point. Moreover, the target for sales of endoscopes is increased to 550,000 units.

"Our business is moving forwards at a solid pace, realising strong organic growth, while also increasing earnings. Our endoscopes continue their impressive development, now with expected sales of 550,000 endoscopes for the year. We are investing heavily in the expansion of our sales force and in product development; this is driving sales at the moment and, more importantly, paving the way for growth for many years to come. Based on the good results in Q3, we are therefore announcing a more precise outlook for organic growth and raising our EBIT margin outlook as well as raising our sales target for endoscopes for the year," says CEO Lars Marcher.

Highlights

  • Revenue of DKK 673m was posted for Q3, representing growth of 17% in local currencies and 12% in Danish kroner. The difference between growth in local currencies and growth in Danish kroner is due primarily to a weakening of the USD/DKK  exchange rate of 8% relative to the same quarter last year.

  • Anaesthesia contributed growth of 10%, Visualisation contributed 47%, and PMD (Patient Monitoring & Diagnostics) delivered growth of 2%, when measured in local currencies.

  • Growth in Europe reached 19%, North America contributed growth of 18%, and the Rest of the World 3%, when measured in local currencies.
  • Sales of endoscopes in Q3 reached 146,000 units, up 54% relative to Q3 last year. Year to date, sales of endoscopes thus totalled 395,000 units, and sales of approx. 550,000 endoscopes are now expected for the year.

  • The gross margin was 59.7% (57.1%), corresponding to an improvement of 2.6 percentage points.

  • Total capacity costs for the quarter were DKK 251m (DKK 213m), corresponding to an 18% increase, inclusive of operating expenses of DKK 20m related to product development and more sales resources in the USA.

  • EBIT was then DKK 151m (DKK 130m) with an EBIT margin of 22.4% (21.6%) for the quarter and 21.2% (18.3%) year to date.

  • Net working capital relative to revenue has increased marginally and now accounts for 22% (21%) of revenue over a rolling 12-month period. 

  • Free cash flows before acquisitions of enterprises totalled DKK 103m (DKK 99m) for the quarter, and DKK 161m (DKK 193m) year to date.  

  • Based on the results for Q3, the financial outlook for 2017/18 is changed. The outlook for organic growth in local currencies is changed from previously 'approx. 14-15%' to a more precise 'approx. 15%', while the EBIT margin is raised from previously 'approx. 20-21%' to now 'approx. 21-22%'.

A conference call is being held today, 23 August 2018, at 11.00 (CET). Please call the following number five minutes before the start of the conference: +45 3544 5580. The conference can be followed via www.ambu.com/webcastQ32018 and is held in English. The presentation can be downloaded immediately before the conference call via the same link.

 

Contact

Lars Marcher, President & CEO, tel. +45 5136 2490, email: lm@ambu.com

Ambu A/S

Baltorpbakken 13

DK-2750 Ballerup

Tel.: +45 7225 2000

CVR no.: 63 64 49 19

www.ambu.com

 

Company announcement no. 32 2017_18


This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Ambu A/S via Globenewswire

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
15 jan
AMBU-B
Det er nok klogere, at du passer paa Hedgefondene (shorterne) N/A NON DDB, som igen i dag staar for ..
16
11 jan
AMBU-B
One of Europe’s Most Hyped Stocks Faces a Record Hedge-Fund Attack https://www.bloomberg.com/news/a..
4
11 jan
AMBU-B
indrømmer gerne, at jeg selv solgte en trediedel af mine i bare skræk og angst, da der for længe sid..
2
17 jan
AMBU-B
Teknisk er der støtte ved ca 133, så jeg vil tro at en snarlig vendning er på vej omend der stadig e..
1
15 jan
AMBU-B
Bunden i den stigende trendkanal liger ved 130. Så jeg venter og ser tiden an.   https://www.trading..
1
15 jan
AMBU-B
Kan næste ikke lade være og købe igen i denne kurs, men med nej i aften fra england til brexit aftal..
1
12 jan
AMBU-B
Nye problemer hos konkurantens. https://borsen.dk/nyheder/virksomheder/artikel/1/375112/ambu-riva..
1
11 jan
AMBU-B
Det synes at være en sensationsoverskrift med underoverskriften: "Det kan gå op, men det kan på den ..
1

Analytiker: Højere DSV-kurs kan holde konkurrenter fra Panalpina-citat

18-01-2019 13:59:53
Der har været god gænge i DSV-aktien, siden at det onsdag kom frem, at transportgiganten har lagt et bud på den schweiziske konkurrent Panalpina.Kursen er nu 9 pct. højere end før buddet, og det øger chancen for, at DSV løber med selskabet. Sådan lyder det ifølge Jyllands-Posten Finans fra Nordea i en analyse.DSV har nemlig tilbudt både kontantbetaling og DSV-aktier for selskabet - og med den stig..

Jyske Bank mister troen på Pandora

18-01-2019 09:54:35
Jyske Bank ser et mindre potentiale i Pandora efter et svagt julesalg. Banken skærer kursmålet med en fjerdedel, så det nu lyder på 300 kr.Torsdag kom der tal fra den amerikanske smykkekæde Signet Jewels, og heraf fremgik det specifikt, at julesalget af Pandora-smykker fra smykkekoncernens amerikanske forhandlere, Jared, var faldet. Julesalget omfatter både november, december og den første uge af ..

Aktier/tendens: Bavarian kommer med godt nyt i positivt marked

18-01-2019 08:32:42
Godt nyt fra Bavarian Nordic kan fredag give aktien en hovedrolle i et i øvrigt positivt marked, hvor investorerne glæder sig over signaler om en kommende løsning på handelskonflikten mellem USA og Kina.De amerikanske aktier steg ganske pænt torsdag, efter at Wall Street Journal skrev, at USA's finansminister, Steven Mnuchin, på interne strategimøder har foreslået, at USA skal rulle den nyindførte..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Aktier/tendens: Bavarian kommer med godt nyt i positivt marked
2
Demokrater raser efter nye beskyldninger mod Trump
3
Zealand/Kempen: Ser kurspotentiale på 70 pct. - GENT
4
Bavarian: Den amerikanske regering udnytter 44 mio. dollar-option
5
Trump får EU-kommissærs nej til stor handelsaftale med EU

Relaterede aktiekurser

Ambu A/S 142,00 0,8% Stigning i aktiekurs

Køb- og salgssignaler

  • Trend
  • Pengemaskinen

Copyright Berlingske Media 2019  Handelsbetingelser  |  Cookiedeklaration  |  Cookie- og Privatlivspolitik  |  Ophavsret og vilkår
Aktieinformation leveres af Morningstar.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
18. januar 2019 17:30:20
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20190108.3 - EUROWEB1 - 2019-01-18 17:30:20 - 2019-01-18 17:30:20 - 1 - Website: OKAY